SLU researchers part of study on gene therapy for heart failure

"Cardiologists at Saint Louis University are participating in what they say are the first-ever clinical trials of gene therapy to treat severe heart failure. Researchers say it could be the first to not only treat symptoms of heart failure but to actually reverse the severity of the disease. Saint Louis University is among 13 research centers involved in the project. The study will investigate whether MYDICAR, a genetically targeted enzyme replacement therapy, can repair heart muscle that was damaged by either a prior heart attack or heart muscle disease. Heart failure affects about 5 million Americans" - KSDK.com